I spoke with Gerald yesterday. He said that the company was in the best position ever.
I asked him about the rumors about Novartis and U of Mass and others related to MANF and diabetes that had been posted on the boards. I said, "I assume you can't comment on them." He laughed and said, "No I definitely can't comment on anything related to diabetes."
He said that the market and shareholders would be updated soon about the company and progress being made.
He also said that the company wouldn't be participating in any investor conferences prior to the J.P. Morgan Healthcare Conference in January. He did say he would be attending some medical conferences.
I asked him specifically if it was realistic to believe that the company could up-list to the NASDAQ or AMEX without a reverse split not that a reverse split would be a bad thing. His answer was that he didn't think a reverse split would be a bad thing in that situation but that his goal was to increase the stock price so that a reverse spit wouldn't be required.
I understand the want to not R/S to up list but the reality is this would basically need to go up approx. 100 X to be at $5 which is a comfortable number to not have to worry about meeting requirements and initial shorting.. ADXS R/S 125 - 1 to get to $5 and initially got shorted or down pressure to $3.50 or so before its starting to get upward movement.. So That's 100 X with no more dilution that's almost unrealistic to think about when we cant barley hold .05 ???? I guess we can dream